The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival

  • D'Souza W
  • Chang C
  • Fischer A
  • et al.
177Citations
Citations of this article
141Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The magnitude of T cell responses is determined by proliferation and survival decisions made by the responding cells. We now demonstrate that the Erk MAPK pathway plays a critical role in these cell fate decisions within CD8 T cells. While Erk1 is dispensable for all aspects of CD8 T cell activation, Erk2 is required for the proliferation of CD8 T cells activated in the absence of costimulation. Surprisingly, Erk2 is not required for proliferation following the addition of a costimulatory signal in vitro, or upon viral infection in vivo, but regulates the size of the responding population by enhancing cell survival. An important component of this Erk2-derived signal is the transcriptional regulation of Bcl-2 family members Bcl-xL and Bim, and impaired Erk2-deficient CD8 T cell survival can be rescued by genetic ablation of Bim. These studies ascribe multifaceted functions specific to Erk2 in CD8 T cell activation, proliferation, and survival.

Cite

CITATION STYLE

APA

D’Souza, W. N., Chang, C.-F., Fischer, A. M., Li, M., & Hedrick, S. M. (2008). The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival. The Journal of Immunology, 181(11), 7617–7629. https://doi.org/10.4049/jimmunol.181.11.7617

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free